ONVO (Organovo Holdings, Inc.) Short-Term Debt to Capital

Organovo Holdings, Inc. (ONVO) creates human tissues via 3D bioprinting, uniting engineers and biologists in an atmosphere of scientific exploration. However, geopolitical fragmentation and trade restrictions hinder the global distribution of equipment. This price chart demonstrates the asset's dynamics, where the indicator stands at 1.90. A high barrier to entry in cellular engineering and an extensive patent portfolio reliably protect the business from new entrants.

For Organovo Holdings, Inc. (ONVO), which is currently in a high-cost R&D phase without revenue, this ratio determines liquidity dependence on short-term liabilities relative to equity, while the short-term financial leverage indicator reflects the risk of accelerated reserve depletion amid prolonged bioprinting tests, where an increase in the metric signals a critical rise in debt load and a threat to solvency.